2-(4-fluorophenyl)sulfinyl-N-[3-[(3S)-3-hydroxy-2-methylbutan-2-yl]-1,2-oxazol-5-yl]-2-methylpropanamide
C18H23FN2O4S — CID 143964863
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-fluorophenyl)sulfinyl-N-[3-[(3S)-3-hydroxy-2-methylbutan-2-yl]-1,2-oxazol-5-yl]-2-methylpropanamide
2-(4-fluorophenyl)sulfinyl-N-[3-[(3S)-3-hydroxy-2-methylbutan-2-yl]-1,2-oxazol-5-yl]-2-methylpropanamide (PubChem CID 143964863) has the molecular formula C18H23FN2O4S and a molecular weight of 382.46 g/mol. Its IUPAC name is 2-(4-fluorophenyl)sulfinyl-N-[3-[(3S)-3-hydroxy-2-methylbutan-2-yl]-1,2-oxazol-5-yl]-2-methylpropanamide.
Molecular Properties
| Compound Name | 2-(4-fluorophenyl)sulfinyl-N-[3-[(3S)-3-hydroxy-2-methylbutan-2-yl]-1,2-oxazol-5-yl]-2-methylpropanamide |
|---|---|
| PubChem CID | 143964863 |
| Molecular Formula | C18H23FN2O4S |
| Molecular Weight | 382.46 g/mol |
| Exact Mass | 382.14 |
| IUPAC Name | 2-(4-fluorophenyl)sulfinyl-N-[3-[(3S)-3-hydroxy-2-methylbutan-2-yl]-1,2-oxazol-5-yl]-2-methylpropanamide |
| SMILES | C[C@H](O)C(C)(C)c1cc(NC(=O)C(C)(C)S(=O)c2ccc(F)cc2)on1 |
| InChI | InChI=1S/C18H23FN2O4S/c1-11(22)17(2,3)14-10-15(25-21-14)20-16(23)18(4,5)26(24)13-8-6-12(19)7-9-13/h6-11,22H,1-5H3,(H,20,23)/t11-,26?/m0/s1 |
| InChIKey | DSBSBGCQRDNRBT-AIGWJHGLSA-N |
| XLogP | 3.00 |
| TPSA | 92.43 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 382.46 |
| LogP ≤ 5 | 3.00 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143964863 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.